NovaBay Pharmaceuticals Inc’s wound cleanser NeutroPhase achieved better results in lab tests, killing bacteria in less than a minute

NovaBay Pharmaceuticals Inc’s wound cleanser NeutroPhase achieved better results in lab tests, killing bacteria in less than a minute Feb 18, 2014 (Menafn – M2 EQUITYBITES via COMTEX) –Biopharmaceutical company NovaBay Pharmaceuticals Inc (nyse mkt:NBY) stated on Monday that its wound cleanser, NeutroPhase, has achieved better results in lab tests than 18 other commercial products.…

Read More

NovaBay’s NeutroPhase(R) is Best in Class in Laboratory Study of 19 Top Commercial Wound Cleansers

NovaBay’s NeutroPhase┬« is Best in Class in Laboratory Study of 19 Top Commercial Wound Cleansers The In Vitro Study, Published in the Peer-Reviewed Journal Advances in Skin & Wound Care, Showed that NeutroPhase┬« Kills Bacteria Quickly Among the Products Tested, NeutroPhase Offered the Best Activity Against Microbes at Concentrations Safe to Mammalian Cells EMERYVILLE, Calif.,…

Read More